查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2010025

醫療圖像市場：2026-2032年全球市場預測（依影像方式、組件、應用、最終用戶、解剖部位和部署方式分類）

Medical Imaging Market by Modality, Component, Application, End User, Anatomy, Deployment Mode - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，醫療圖像市場價值將達到 704.6 億美元，到 2026 年將成長至 796.3 億美元，到 2032 年將達到 1880.7 億美元，複合年成長率為 15.05%。

主要市場統計數據
基準年 2025 704.6億美元
預計年份：2026年 796.3億美元
預測年份 2032 1880.7億美元
複合年成長率 (%) 15.05%

一個簡潔的框架，用於描述不斷發展的醫療圖像生態系統，將模式創新、臨床需求和營運要求與策略決策連結起來。

醫療圖像領域正處於快速技術創新、不斷演進的臨床路徑以及所有醫療機構日益成長的營運壓力交匯點。影像擷取、處理演算法和資訊學的進步拓展了診斷能力，同時也提高了人們對互通性、資料安全性和工作流程效率的期望。同時，醫療系統也在努力改善治療效果並控制成本，這使得對既能展現臨床價值又能無縫整合到更廣泛的數位健康生態系統中的影像解決方案的需求日益成長。

模式進步、人工智慧軟體、整合服務和混合分銷模式如何重新定義競爭優勢和臨床應用動態。

一場重大變革正在重塑診斷影像技術的開發、實施和使用方式，這要求製造商、醫療服務提供者和保險公司都積極做出調整。人工智慧 (AI) 和先進的影像分析技術正在加速診斷處理能力並增強臨床解讀，從而改變了人們對軟體和資料管理的期望，無論這些軟體和資料是部署在本地還是雲端部署。同時，從電腦斷層掃描 (CT) 的進步（例如錐狀射束CT、PET-CT 混合成像和頻譜成像），到磁振造影(MRI) 和不斷擴展的光學成像方式，硬體的進步正在持續推動解析度和功能洞察力的提升。

本研究評估了新的關稅政策如何使供應鏈複雜化，促使製造地向區域內轉移，並改變耐用醫療影像技術的採購重點。

2025年關稅和貿易措施的實施將對整個醫療圖像供應鏈產生影響，波及採購選擇、採購週期以及與供應商的關係。先前依賴跨境進口零件和成品的供應商正面臨投入成本上升和前置作業時間延長的困境，促使客戶和製造商重新評估籌資策略。為此，一些製造商正在加快區域製造和組裝以降低關稅風險，而另一些製造商則在與供應商重新談判合約或探索替代物流路線，以維持交貨時間和利潤結構。

從細分市場的觀點揭示了模式功能、軟體和服務生態系統以及部署偏好如何相互作用並決定臨床和商業性成功。

分析細分市場層面的趨勢揭示了不同模式、組件、應用、終端用戶、解剖靶區、交付模式和分銷管道所面臨的差異化機會和營運挑戰。電腦斷層掃描（CT），包括錐狀射束CT、PET-CT和頻譜CT等變體，因其高速和多能量成像能力可提高診斷清晰度，持續吸引投資；而磁振造影（MRI）系統則在軟組織對比度和先進序列技術有助於治療計劃的領域推動著需求。核子醫學影像在分子診斷中發揮著至關重要的作用，尤其是在腫瘤學和神經病學領域，正子斷層掃描（PET）和單光子發射電腦斷層掃描（SPECT）的應用尤為突出。同時，光學成像和超音波正在拓展其診斷應用，包括術中引導和床邊評估。 X光系統在急診醫學和常規臨床實踐中仍然至關重要，數位化的應用提高了工作流程和影像品質。

基礎設施、還款方案、監管方法和製造能力的區域趨勢決定了採用途徑和打入市場策略的差異。

區域趨勢凸顯了基礎設施成熟度、報銷環境、法律規範和製造地如何影響技術應用軌跡和策略重點。在美洲，資本投資能力、先進的醫院網路和完善的監管管道正在推動高階技術和分析主導解決方案的快速普及，同時也為健全的售後服務模式提供了支援。過渡性資金籌措機制和私營部門的創新正在促進夥伴關係的建立，從而加速新興影像技術的臨床應用。

主要企業如何透過收購、人工智慧夥伴關係、本地化服務和靈活分銷來建立強大的產品組合併擴大其在臨床領域的覆蓋範圍？

醫療圖像領域的競爭格局是由產品創新、策略夥伴關係、售後服務以及對軟體和數據能力的定向投資共同塑造的。主要企業正透過收購、與人工智慧專家合作以及與臨床研究中心合作來拓展產品組合，以加速新應用的檢驗和監管核准。這些措施旨在建構一個整合的生態系統，將成像硬體、分析主導軟體和全面的服務產品結合，從而降低應用門檻並提升產品生命週期價值。

一套實用且多方面的策略手冊，將產品模組化、軟體和服務、供應鏈彈性以及區域上市時間策略相結合，以確保永續的競爭優勢。

產業領導企業必須採取切實可行的多方位策略方案，以最大限度地掌握機遇，同時降低營運和政策風險。首先，優先考慮模組化和在地化設計，以降低關稅成本波動的影響，並實現在地化的快速組裝和配置。其次，增加對提升硬體價值的軟體和服務的投資，特別是人工智慧驅動的分析、雲端或混合數據管理以及臨床醫生培訓，以創造持續的收入來源並提高客戶維繫。第三，透過多元化採購、關鍵零件的策略性庫存緩衝以及應對貿易突發事件的合約保障措施，提高供應鏈透明度。

透過採用以證據為基礎的調查方法，結合專家訪談、系統性文獻分析、情境評估和交叉檢驗，我們獲得了嚴謹而實用的見解。

本研究途徑整合了第一手和第二手調查，建構了可靠的證據基礎，並透過相關人員三​​角檢驗檢驗了主題研究結果。第一手調查包括對臨床負責人、採購專家、放射科醫生以及製造商和分銷商高管進行結構化訪談，並進行專家訪談，以直接了解營運挑戰、應用促進因素和服務期望。第二手調查包括對同行評審文獻、監管指南、專利申請、公司資訊披露和技術白皮書進行系統性回顧，以闡明技術趨勢和歷史發展。

一份簡潔、全面的分析報告，將技術進步、服務主導的差異化和價值鏈韌性連結起來，作為永續採用和價值交付的核心決定因素。

總而言之，在硬體、分析技術和服務交付模式的進步融合以及政策和採購趨勢轉變的共同推動下，醫療圖像領域正經歷持續的變革。儘管特定成像方式的創新不斷拓展診斷和治療能力，但決定性的差異化因素正日益轉向軟體整合、售後服務和供應鏈的適應性。貿易政策趨勢凸顯了在地化、模組化設計和採購多元化的重要性，促使相關人員重新評估其採購框架，並在整個生命週期中優先考慮價值。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：醫療圖像市場：依影像方式分類

  • 電腦斷層掃描
    • 錐狀射束CT
    • PET-CT
    • 頻譜CT
  • 磁振造影
  • 核子醫學掃描術診斷
    • 正子斷層掃描
    • 單光子發射電腦斷層掃描
  • 光學成像
  • 超音波
  • X光

第9章：醫療圖像市場：依組件分類

  • 硬體
  • 服務
    • 安裝與整合
    • 維護和支援
    • 培訓和教育
  • 軟體

第10章：醫療圖像市場：依應用領域分類

  • 循環系統
  • 胃腸病學
  • 神經病學
  • 婦產科
  • 腫瘤學
  • 整形外科
  • 泌尿系統

第11章：醫療圖像市場：依最終使用者分類

  • 門診手術中心
  • 診所
  • 診斷影像中心
  • 醫院

第12章 按解剖部位分類的醫療圖像市場

  • 腹部
  • 腦
  • 胸部
  • 心血管系統
  • 肌肉骨骼系統
  • 兒童
  • 脊椎

第13章：醫療圖像市場：依部署模式分類

  • 雲
  • 現場

第14章：醫療圖像市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第15章：醫療圖像市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章醫療圖像市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章：美國醫療圖像市場

第18章：中國醫療圖像市場

第19章 競爭情勢

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Agfa-Gevaert Group
  • Analogic Corporation
  • Bracco Imaging SpA
  • Canon Medical Systems Corporation
  • Carestream Health, Inc.
  • Carl Zeiss Meditec AG
  • Esaote SpA
  • Fujifilm Holdings Corporation
  • GE HealthCare Technologies Inc.
  • Hitachi, Ltd.
  • Hologic, Inc.
  • Konica Minolta, Inc.
  • Koninklijke Philips NV
  • Mindray Medical International Limited
  • Planmeca Oy
  • RadNet, Inc.
  • Samsung Medison Co., Ltd.
  • Shimadzu Corporation
  • Siemens Healthineers AG
  • Varex Imaging Corporation
Product Code: MRR-434CCDA04E90

The Medical Imaging Market was valued at USD 70.46 billion in 2025 and is projected to grow to USD 79.63 billion in 2026, with a CAGR of 15.05%, reaching USD 188.07 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 70.46 billion
Estimated Year [2026] USD 79.63 billion
Forecast Year [2032] USD 188.07 billion
CAGR (%) 15.05%

A concise framing of the evolving medical imaging ecosystem that links modality innovation, clinical demand, and operational imperatives to strategic decision-making

The medical imaging landscape sits at the intersection of rapid technological innovation, evolving clinical pathways, and intensifying operational pressures across care settings. Advances in image acquisition, processing algorithms, and informatics have expanded diagnostic capabilities while simultaneously raising expectations for interoperability, data security, and workflow efficiency. Meanwhile, health systems pursue improved outcomes and cost management, which amplifies demand for imaging solutions that demonstrate clinical value and seamless integration into broader digital health ecosystems.

Against this backdrop, stakeholders from manufacturers to hospital procurement teams are reassessing investment priorities. Vendors are moving beyond single-product strategies toward software-enabled platforms and service-centric models that support lifecycle value and recurring revenue. Clinicians increasingly rely on multimodal imaging to guide diagnosis and therapy, which elevates the importance of modality-specific strengths and integration across modalities. Consequently, decision-makers must consider not only technology performance but also supply chain resilience, regulatory compliance, and the workforce implications of adopting advanced imaging tools.

In the following sections, the report synthesizes how modality innovation, component ecosystems, application-specific requirements, end-user dynamics, anatomical focus areas, deployment preferences, and distribution approaches collectively shape strategic opportunities and operational risks for organizations across the medical imaging value chain.

How modality advancements, AI-enabled software, integrated services, and hybrid distribution models are collectively redefining competitive advantage and clinical adoption dynamics

Major disruptive forces are reshaping how imaging technologies are developed, deployed, and consumed, and these shifts demand proactive adaptation from manufacturers, providers, and payers alike. Artificial intelligence and advanced image analytics are accelerating diagnostic throughput and augmenting clinical interpretation, which in turn changes expectations for software and data management across on-premise and cloud deployment modes. At the same time, hardware evolution-spanning computed tomography with advances such as cone beam CT, PET-CT hybrids and spectral imaging, to magnetic resonance and expanding optical imaging modalities-continues to enhance resolution and functional insights.

Simultaneously, nuclear imaging retains importance for metabolic and molecular assessments, with positron emission tomography and single photon emission computed tomography driving specialized clinical protocols. Ultrasound and X-ray remain indispensable for point-of-care and routine diagnostics, prompting manufacturers to invest in portability and user-friendly interfaces. Component ecosystems are shifting toward integrated offerings where hardware, software, and services such as installation, maintenance and targeted training converge to deliver measurable value. Furthermore, distribution strategies that blend direct sales with indirect channels including dealers, distributors and online retailers are optimizing reach and aftermarket support, while end users from hospitals and diagnostic imaging centers to clinics and ambulatory surgical centers demand flexible pricing and deployment options. As a result, organizations must craft strategies that align modality strengths with application areas such as cardiology, oncology and neurology, account for anatomical focus from cardiovascular to pediatric imaging, and balance cloud-enabled analytics with on-premise control to meet clinical, security and operational objectives.

Assessing how new tariff policies introduce supply chain complexity, prompt regional manufacturing shifts, and alter procurement priorities for durable imaging technologies

The introduction of tariffs and trade measures in 2025 has reverberated across the medical imaging supply chain, influencing sourcing choices, procurement cycles, and supplier relationships. Suppliers that previously relied on cross-border components and finished equipment imports have faced increased input costs and longer lead times, prompting both customers and manufacturers to reevaluate their procurement strategies. In response, some manufacturers have accelerated regional manufacturing or assembly to mitigate tariff exposure, while others have renegotiated supplier contracts or pursued alternative logistics pathways to preserve delivery schedules and margin structures.

Consequently, health systems and imaging providers have reassessed capital procurement priorities and service agreements, often emphasizing total cost of ownership and long-term serviceability over short-term price reductions. The tariffs have also intensified discussions around vendor diversification, with procurement teams seeking multi-sourced options to reduce concentration risk. Moreover, regulatory compliance and documentation requirements associated with cross-border trade have added administrative complexity, influencing lead times for installation and integration services. Importantly, these dynamics have strengthened the strategic significance of aftermarket services and localized support, as providers place higher value on reliable maintenance, rapid spare parts availability, and vendor responsiveness to sustain clinical operations.

Looking ahead, the cumulative impact of trade policy is encouraging stakeholders to invest in supply chain transparency, scenario planning, and contractual terms that explicitly address tariff contingencies. In parallel, manufacturers are evaluating product redesign and modularization approaches to localize higher-value components and reduce tariff exposure, thereby preserving competitiveness while maintaining clinical performance and safety standards.

Segment-level perspectives that reveal how modality capabilities, software and service ecosystems, and deployment preferences interact to determine clinical and commercial success

Examining segment-level dynamics reveals differentiated opportunities and operational challenges across modalities, components, applications, end users, anatomical focus areas, deployment modes, and distribution channels. Computed tomography, including cone beam CT, PET-CT and spectral CT variants, continues to attract investment where speed and multi-energy imaging deliver diagnostic clarity, while magnetic resonance systems drive demand where soft tissue contrast and advanced sequences inform therapeutic decision-making. Nuclear imaging maintains a crucial role for molecular diagnostics via positron emission tomography and single photon emission computed tomography, especially in oncology and neurology, whereas optical imaging and ultrasound extend diagnostic reach to intraoperative guidance and point-of-care assessment. X-ray systems remain foundational across emergency and routine care settings, benefitting from digital upgrades that enhance workflow and image quality.

From a component perspective, hardware remains fundamental to imaging performance, but software and services increasingly determine differentiation. Service bundles that include installation and integration, robust maintenance and support, and clinician-focused training and education enable faster clinical adoption and higher uptime. Application-driven requirements steer modality selection: cardiology and oncology demand high-resolution, reproducible protocols and advanced analytics, while obstetrics, orthopedics and pediatrics emphasize patient comfort, dose optimization and tailored workflow solutions. End users such as hospitals and diagnostic imaging centers prioritize scalability, accreditation support and comprehensive service agreements, whereas clinics and ambulatory surgical centers often value compact form factors, cost-effective deployment models and simplified maintenance.

Anatomical focus areas-from cardiovascular and brain imaging to breast and spine diagnostics-shape device specifications, imaging protocols and reporting tools. Deployment mode choices between cloud and on-premise arrangements hinge on data governance, latency requirements and institutional IT strategies, and distribution approaches that combine direct sales with indirect channels like dealers, distributors and online retailers influence market reach and aftermarket responsiveness. Collectively, these segmentation insights underscore that winning strategies integrate modality-specific innovation, software-enabled workflows and service-driven support tailored to the unique needs of clinical applications and care settings.

Regional patterns in infrastructure, reimbursement, regulatory approaches, and manufacturing capacity that determine differentiated adoption pathways and go-to-market strategies

Regional dynamics underscore how infrastructure maturity, reimbursement environments, regulatory frameworks, and manufacturing footprints influence adoption trajectories and strategic priorities. In the Americas, capital investment capacity, advanced hospital networks, and established regulatory pathways have fostered rapid uptake of high-end modalities and analytics-driven solutions, while also supporting robust aftermarket service models. Transitional funding mechanisms and private sector innovation encourage partnerships that accelerate clinical integration of emerging imaging technologies.

Across Europe, the Middle East and Africa, heterogeneous healthcare systems and varied reimbursement approaches create differentiated demand patterns; some markets prioritize cost-effective, portable imaging solutions to extend diagnostic reach, while others emphasize high-acuity modalities paired with sophisticated data management to support complex clinical pathways. Regulatory harmonization efforts and regional collaborations influence cross-border procurement and supply chain planning. Meanwhile, Asia-Pacific exhibits a mix of advanced technology adoption in urban centers and growing demand for scalable, portable, and tele-enabled imaging in underserved areas. Rapidly expanding hospital infrastructure, growing local manufacturing capabilities and strategic government investments in health technology drive dynamic vendor strategies and partnerships across the region.

Taken together, these regional distinctions require vendors and providers to calibrate product portfolios, service offerings, and distribution models to local clinical needs, regulatory requirements and procurement practices, while leveraging regional strengths such as manufacturing hubs, telehealth networks, and public-private partnerships to optimize access and operational resilience.

How leading firms are combining acquisitions, AI partnerships, localized services, and flexible distribution to build resilient portfolios and expand clinical reach

Competitive trajectories within the medical imaging landscape are shaped by a mix of product innovation, strategic partnerships, aftermarket services, and targeted investments in software and data capabilities. Leading firms are broadening portfolios through acquisitions, alliances with AI specialists and collaborations with clinical research centers to validate new applications and accelerate regulatory approvals. These efforts aim to create integrated ecosystems that combine modality hardware, analytics-driven software, and comprehensive service offerings that reduce adoption friction and enhance lifecycle value.

At the same time, an emergent cohort of specialized vendors focuses on niche segments such as portable ultrasound, spectral CT enhancements or cloud-native image management, compelling larger incumbents to adopt flexible partnership models. Aftermarket service differentiation-encompassing rapid installation, preventative maintenance, spare parts logistics and clinician training-has become a competitive lever, particularly when supply chain uncertainties amplify the value of localized support. Moreover, distribution strategies that incorporate both direct engagement with large health systems and indirect channels to extend reach into ambulatory care and clinics allow companies to optimize coverage and responsiveness. As stakeholders prioritize interoperability and open architectures, companies that invest in standards-based integration and developer ecosystems are better positioned to capture long-term value and expand into adjacent digital health domains.

A practical, multi-pronged strategic playbook that aligns product modularity, software and services, supply chain resilience, and regional go-to-market execution for sustained advantage

Industry leaders must adopt a pragmatic, multi-dimensional playbook to capitalize on opportunities while mitigating operational and policy risks. First, prioritize product modularity and design for localization to reduce exposure to tariff-driven cost volatility and enable faster regional assembly or configuration. Second, deepen investments in software and services that augment hardware value-particularly AI-enabled analytics, cloud or hybrid data management and clinician-focused training-to create recurring revenue streams and improve retention. Third, strengthen supply chain transparency through multi-sourcing, strategic inventory buffers for critical components, and contractual protections that address trade contingencies.

In parallel, align go-to-market approaches with regional nuances by tailoring pricing and distribution models to local procurement practices and end-user capabilities, while ensuring robust aftermarket arrangements that guarantee uptime and parts availability. Foster strategic partnerships with systems integrators, clinical networks and technology vendors to enhance interoperability and accelerate clinical validation. Finally, embed data governance, cybersecurity and regulatory readiness into product development and service delivery to meet institutional expectations and expedite procurement decisions. Taken together, these actions enable organizations to sustain competitiveness, support clinical adoption, and adapt to a rapidly evolving policy and technology environment.

An evidence-driven methodology combining expert interviews, systematic literature analysis, scenario assessment, and cross-validation to ensure rigorous and actionable insights

The research approach integrated primary and secondary methods to generate a robust evidence base and validate thematic findings through stakeholder triangulation. Primary research comprised structured interviews and expert consultations with clinical leaders, procurement specialists, imaging technologists, and senior executives from manufacturers and distributors, enabling direct insight into operational challenges, adoption drivers, and service expectations. Secondary research involved systematic review of peer-reviewed literature, regulatory guidance, patent filings, company disclosures and technical whitepapers to map technology trends and historical developments.

Data synthesis employed qualitative coding to identify recurring themes and quantitative aggregation where appropriate to describe adoption patterns and service models, while scenario-based analysis explored the implications of policy shifts, such as trade measures, on supply chains and procurement behavior. To ensure rigor, findings were cross-validated with independent expert panels and reconciled against known regulatory and clinical standards. Limitations included variability in publicly available operational metrics across regions and the evolving nature of AI and software regulations, which necessitated careful contextualization and conservative interpretation of near-term implications. Ethical considerations guided interview protocols and data handling to protect confidentiality and ensure objective analysis.

A concise synthesis that connects technology progress, service-driven differentiation, and supply chain resilience as the core determinants of sustained adoption and value delivery

In synthesis, the medical imaging sector is undergoing a sustained period of transformation driven by converging advances in hardware, analytics, and service delivery models alongside shifting policy and procurement dynamics. Modality-specific innovation continues to expand diagnostic and therapeutic capabilities, but the decisive differentiators increasingly reside in software integration, aftermarket services and supply chain adaptability. Trade policy developments have heightened the importance of localization, modular design and diversified sourcing, prompting stakeholders to reassess procurement frameworks and prioritize total lifecycle value.

Going forward, successful organizations will balance investment in core imaging performance with strategic software capabilities, clinician-centered training programs, and resilient distribution and service networks that accommodate regional nuances. By aligning product design, commercial models and operational processes with the realities of regulatory environments, deployment preferences and end-user needs, vendors and providers can better support clinical outcomes while preserving financial and operational stability. Ultimately, a deliberate focus on interoperability, service excellence and risk-managed supply chains will underpin sustained adoption and innovation across care settings.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Medical Imaging Market, by Modality

  • 8.1. Computed Tomography
    • 8.1.1. Cone Beam CT
    • 8.1.2. PET-CT
    • 8.1.3. Spectral CT
  • 8.2. Magnetic Resonance Imaging
  • 8.3. Nuclear Imaging
    • 8.3.1. Positron Emission Tomography
    • 8.3.2. Single Photon Emission Computed Tomography
  • 8.4. Optical Imaging
  • 8.5. Ultrasound
  • 8.6. X Ray

9. Medical Imaging Market, by Component

  • 9.1. Hardware
  • 9.2. Services
    • 9.2.1. Installation & Integration
    • 9.2.2. Maintenance & Support
    • 9.2.3. Training & Education
  • 9.3. Software

10. Medical Imaging Market, by Application

  • 10.1. Cardiology
  • 10.2. Gastroenterology
  • 10.3. Neurology
  • 10.4. Obstetrics & Gynecology
  • 10.5. Oncology
  • 10.6. Orthopedics
  • 10.7. Urology

11. Medical Imaging Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Clinics
  • 11.3. Diagnostic Imaging Centers
  • 11.4. Hospitals

12. Medical Imaging Market, by Anatomy

  • 12.1. Abdominal
  • 12.2. Brain
  • 12.3. Breast
  • 12.4. Cardiovascular
  • 12.5. Musculoskeletal
  • 12.6. Pediatrics
  • 12.7. Spine

13. Medical Imaging Market, by Deployment Mode

  • 13.1. Cloud
  • 13.2. On Premise

14. Medical Imaging Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Medical Imaging Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Medical Imaging Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Medical Imaging Market

18. China Medical Imaging Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. Agfa-Gevaert Group
  • 19.6. Analogic Corporation
  • 19.7. Bracco Imaging S.p.A.
  • 19.8. Canon Medical Systems Corporation
  • 19.9. Carestream Health, Inc.
  • 19.10. Carl Zeiss Meditec AG
  • 19.11. Esaote S.p.A.
  • 19.12. Fujifilm Holdings Corporation
  • 19.13. GE HealthCare Technologies Inc.
  • 19.14. Hitachi, Ltd.
  • 19.15. Hologic, Inc.
  • 19.16. Konica Minolta, Inc.
  • 19.17. Koninklijke Philips N.V.
  • 19.18. Mindray Medical International Limited
  • 19.19. Planmeca Oy
  • 19.20. RadNet, Inc.
  • 19.21. Samsung Medison Co., Ltd.
  • 19.22. Shimadzu Corporation
  • 19.23. Siemens Healthineers AG
  • 19.24. Varex Imaging Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL MEDICAL IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL MEDICAL IMAGING MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL MEDICAL IMAGING MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL MEDICAL IMAGING MARKET SIZE, BY MODALITY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL MEDICAL IMAGING MARKET SIZE, BY COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL MEDICAL IMAGING MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL MEDICAL IMAGING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL MEDICAL IMAGING MARKET SIZE, BY ANATOMY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL MEDICAL IMAGING MARKET SIZE, BY DEPLOYMENT MODE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL MEDICAL IMAGING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL MEDICAL IMAGING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL MEDICAL IMAGING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES MEDICAL IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA MEDICAL IMAGING MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL MEDICAL IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL MEDICAL IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL MEDICAL IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL MEDICAL IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL MEDICAL IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL MEDICAL IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL MEDICAL IMAGING MARKET SIZE, BY CONE BEAM CT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL MEDICAL IMAGING MARKET SIZE, BY CONE BEAM CT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL MEDICAL IMAGING MARKET SIZE, BY CONE BEAM CT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL MEDICAL IMAGING MARKET SIZE, BY PET-CT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL MEDICAL IMAGING MARKET SIZE, BY PET-CT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL MEDICAL IMAGING MARKET SIZE, BY PET-CT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL MEDICAL IMAGING MARKET SIZE, BY SPECTRAL CT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL MEDICAL IMAGING MARKET SIZE, BY SPECTRAL CT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL MEDICAL IMAGING MARKET SIZE, BY SPECTRAL CT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL MEDICAL IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL MEDICAL IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL MEDICAL IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL MEDICAL IMAGING MARKET SIZE, BY NUCLEAR IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL MEDICAL IMAGING MARKET SIZE, BY NUCLEAR IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL MEDICAL IMAGING MARKET SIZE, BY NUCLEAR IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL MEDICAL IMAGING MARKET SIZE, BY NUCLEAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL MEDICAL IMAGING MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL MEDICAL IMAGING MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL MEDICAL IMAGING MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL MEDICAL IMAGING MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL MEDICAL IMAGING MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL MEDICAL IMAGING MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL MEDICAL IMAGING MARKET SIZE, BY OPTICAL IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL MEDICAL IMAGING MARKET SIZE, BY OPTICAL IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL MEDICAL IMAGING MARKET SIZE, BY OPTICAL IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL MEDICAL IMAGING MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL MEDICAL IMAGING MARKET SIZE, BY ULTRASOUND, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL MEDICAL IMAGING MARKET SIZE, BY ULTRASOUND, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL MEDICAL IMAGING MARKET SIZE, BY X RAY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL MEDICAL IMAGING MARKET SIZE, BY X RAY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL MEDICAL IMAGING MARKET SIZE, BY X RAY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL MEDICAL IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL MEDICAL IMAGING MARKET SIZE, BY HARDWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL MEDICAL IMAGING MARKET SIZE, BY HARDWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL MEDICAL IMAGING MARKET SIZE, BY HARDWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL MEDICAL IMAGING MARKET SIZE, BY SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL MEDICAL IMAGING MARKET SIZE, BY SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL MEDICAL IMAGING MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL MEDICAL IMAGING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL MEDICAL IMAGING MARKET SIZE, BY INSTALLATION & INTEGRATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL MEDICAL IMAGING MARKET SIZE, BY INSTALLATION & INTEGRATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL MEDICAL IMAGING MARKET SIZE, BY INSTALLATION & INTEGRATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL MEDICAL IMAGING MARKET SIZE, BY MAINTENANCE & SUPPORT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL MEDICAL IMAGING MARKET SIZE, BY MAINTENANCE & SUPPORT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL MEDICAL IMAGING MARKET SIZE, BY MAINTENANCE & SUPPORT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL MEDICAL IMAGING MARKET SIZE, BY TRAINING & EDUCATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL MEDICAL IMAGING MARKET SIZE, BY TRAINING & EDUCATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL MEDICAL IMAGING MARKET SIZE, BY TRAINING & EDUCATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL MEDICAL IMAGING MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL MEDICAL IMAGING MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL MEDICAL IMAGING MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL MEDICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL MEDICAL IMAGING MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL MEDICAL IMAGING MARKET SIZE, BY CARDIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL MEDICAL IMAGING MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL MEDICAL IMAGING MARKET SIZE, BY GASTROENTEROLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL MEDICAL IMAGING MARKET SIZE, BY GASTROENTEROLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL MEDICAL IMAGING MARKET SIZE, BY GASTROENTEROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL MEDICAL IMAGING MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL MEDICAL IMAGING MARKET SIZE, BY NEUROLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL MEDICAL IMAGING MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL MEDICAL IMAGING MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL MEDICAL IMAGING MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL MEDICAL IMAGING MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL MEDICAL IMAGING MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL MEDICAL IMAGING MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL MEDICAL IMAGING MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL MEDICAL IMAGING MARKET SIZE, BY ORTHOPEDICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL MEDICAL IMAGING MARKET SIZE, BY ORTHOPEDICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL MEDICAL IMAGING MARKET SIZE, BY ORTHOPEDICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL MEDICAL IMAGING MARKET SIZE, BY UROLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL MEDICAL IMAGING MARKET SIZE, BY UROLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL MEDICAL IMAGING MARKET SIZE, BY UROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL MEDICAL IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL MEDICAL IMAGING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL MEDICAL IMAGING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL MEDICAL IMAGING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL MEDICAL IMAGING MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL MEDICAL IMAGING MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL MEDICAL IMAGING MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL MEDICAL IMAGING MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL MEDICAL IMAGING MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL MEDICAL IMAGING MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL MEDICAL IMAGING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL MEDICAL IMAGING MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL MEDICAL IMAGING MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL MEDICAL IMAGING MARKET SIZE, BY ANATOMY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL MEDICAL IMAGING MARKET SIZE, BY ABDOMINAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL MEDICAL IMAGING MARKET SIZE, BY ABDOMINAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL MEDICAL IMAGING MARKET SIZE, BY ABDOMINAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL MEDICAL IMAGING MARKET SIZE, BY BRAIN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL MEDICAL IMAGING MARKET SIZE, BY BRAIN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL MEDICAL IMAGING MARKET SIZE, BY BRAIN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL MEDICAL IMAGING MARKET SIZE, BY BREAST, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL MEDICAL IMAGING MARKET SIZE, BY BREAST, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL MEDICAL IMAGING MARKET SIZE, BY BREAST, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL MEDICAL IMAGING MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL MEDICAL IMAGING MARKET SIZE, BY CARDIOVASCULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL MEDICAL IMAGING MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL MEDICAL IMAGING MARKET SIZE, BY MUSCULOSKELETAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL MEDICAL IMAGING MARKET SIZE, BY MUSCULOSKELETAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL MEDICAL IMAGING MARKET SIZE, BY MUSCULOSKELETAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL MEDICAL IMAGING MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL MEDICAL IMAGING MARKET SIZE, BY PEDIATRICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL MEDICAL IMAGING MARKET SIZE, BY PEDIATRICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL MEDICAL IMAGING MARKET SIZE, BY SPINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL MEDICAL IMAGING MARKET SIZE, BY SPINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL MEDICAL IMAGING MARKET SIZE, BY SPINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL MEDICAL IMAGING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL MEDICAL IMAGING MARKET SIZE, BY CLOUD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL MEDICAL IMAGING MARKET SIZE, BY CLOUD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL MEDICAL IMAGING MARKET SIZE, BY CLOUD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL MEDICAL IMAGING MARKET SIZE, BY ON PREMISE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL MEDICAL IMAGING MARKET SIZE, BY ON PREMISE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL MEDICAL IMAGING MARKET SIZE, BY ON PREMISE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL MEDICAL IMAGING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 123. AMERICAS MEDICAL IMAGING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 124. AMERICAS MEDICAL IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 125. AMERICAS MEDICAL IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 126. AMERICAS MEDICAL IMAGING MARKET SIZE, BY NUCLEAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 127. AMERICAS MEDICAL IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 128. AMERICAS MEDICAL IMAGING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 129. AMERICAS MEDICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 130. AMERICAS MEDICAL IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 131. AMERICAS MEDICAL IMAGING MARKET SIZE, BY ANATOMY, 2018-2032 (USD MILLION)
  • TABLE 132. AMERICAS MEDICAL IMAGING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 133. NORTH AMERICA MEDICAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 134. NORTH AMERICA MEDICAL IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 135. NORTH AMERICA MEDICAL IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 136. NORTH AMERICA MEDICAL IMAGING MARKET SIZE, BY NUCLEAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 137. NORTH AMERICA MEDICAL IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 138. NORTH AMERICA MEDICAL IMAGING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 139. NORTH AMERICA MEDICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 140. NORTH AMERICA MEDICAL IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 141. NORTH AMERICA MEDICAL IMAGING MARKET SIZE, BY ANATOMY, 2018-2032 (USD MILLION)
  • TABLE 142. NORTH AMERICA MEDICAL IMAGING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 143. LATIN AMERICA MEDICAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. LATIN AMERICA MEDICAL IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 145. LATIN AMERICA MEDICAL IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 146. LATIN AMERICA MEDICAL IMAGING MARKET SIZE, BY NUCLEAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 147. LATIN AMERICA MEDICAL IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 148. LATIN AMERICA MEDICAL IMAGING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 149. LATIN AMERICA MEDICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 150. LATIN AMERICA MEDICAL IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 151. LATIN AMERICA MEDICAL IMAGING MARKET SIZE, BY ANATOMY, 2018-2032 (USD MILLION)
  • TABLE 152. LATIN AMERICA MEDICAL IMAGING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA MEDICAL IMAGING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA MEDICAL IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA MEDICAL IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA MEDICAL IMAGING MARKET SIZE, BY NUCLEAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA MEDICAL IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA MEDICAL IMAGING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE, MIDDLE EAST & AFRICA MEDICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE, MIDDLE EAST & AFRICA MEDICAL IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE, MIDDLE EAST & AFRICA MEDICAL IMAGING MARKET SIZE, BY ANATOMY, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE, MIDDLE EAST & AFRICA MEDICAL IMAGING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE MEDICAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPE MEDICAL IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPE MEDICAL IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPE MEDICAL IMAGING MARKET SIZE, BY NUCLEAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPE MEDICAL IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPE MEDICAL IMAGING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPE MEDICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPE MEDICAL IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPE MEDICAL IMAGING MARKET SIZE, BY ANATOMY, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPE MEDICAL IMAGING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 173. MIDDLE EAST MEDICAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 174. MIDDLE EAST MEDICAL IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 175. MIDDLE EAST MEDICAL IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 176. MIDDLE EAST MEDICAL IMAGING MARKET SIZE, BY NUCLEAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 177. MIDDLE EAST MEDICAL IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 178. MIDDLE EAST MEDICAL IMAGING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 179. MIDDLE EAST MEDICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 180. MIDDLE EAST MEDICAL IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 181. MIDDLE EAST MEDICAL IMAGING MARKET SIZE, BY ANATOMY, 2018-2032 (USD MILLION)
  • TABLE 182. MIDDLE EAST MEDICAL IMAGING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 183. AFRICA MEDICAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 184. AFRICA MEDICAL IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 185. AFRICA MEDICAL IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 186. AFRICA MEDICAL IMAGING MARKET SIZE, BY NUCLEAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 187. AFRICA MEDICAL IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 188. AFRICA MEDICAL IMAGING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 189. AFRICA MEDICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 190. AFRICA MEDICAL IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 191. AFRICA MEDICAL IMAGING MARKET SIZE, BY ANATOMY, 2018-2032 (USD MILLION)
  • TABLE 192. AFRICA MEDICAL IMAGING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 193. ASIA-PACIFIC MEDICAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 194. ASIA-PACIFIC MEDICAL IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 195. ASIA-PACIFIC MEDICAL IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 196. ASIA-PACIFIC MEDICAL IMAGING MARKET SIZE, BY NUCLEAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 197. ASIA-PACIFIC MEDICAL IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 198. ASIA-PACIFIC MEDICAL IMAGING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 199. ASIA-PACIFIC MEDICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 200. ASIA-PACIFIC MEDICAL IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 201. ASIA-PACIFIC MEDICAL IMAGING MARKET SIZE, BY ANATOMY, 2018-2032 (USD MILLION)
  • TABLE 202. ASIA-PACIFIC MEDICAL IMAGING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 203. GLOBAL MEDICAL IMAGING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 204. ASEAN MEDICAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 205. ASEAN MEDICAL IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 206. ASEAN MEDICAL IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 207. ASEAN MEDICAL IMAGING MARKET SIZE, BY NUCLEAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 208. ASEAN MEDICAL IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 209. ASEAN MEDICAL IMAGING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 210. ASEAN MEDICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 211. ASEAN MEDICAL IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 212. ASEAN MEDICAL IMAGING MARKET SIZE, BY ANATOMY, 2018-2032 (USD MILLION)
  • TABLE 213. ASEAN MEDICAL IMAGING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 214. GCC MEDICAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 215. GCC MEDICAL IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 216. GCC MEDICAL IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 217. GCC MEDICAL IMAGING MARKET SIZE, BY NUCLEAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 218. GCC MEDICAL IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 219. GCC MEDICAL IMAGING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 220. GCC MEDICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 221. GCC MEDICAL IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 222. GCC MEDICAL IMAGING MARKET SIZE, BY ANATOMY, 2018-2032 (USD MILLION)
  • TABLE 223. GCC MEDICAL IMAGING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPEAN UNION MEDICAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 225. EUROPEAN UNION MEDICAL IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 226. EUROPEAN UNION MEDICAL IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 227. EUROPEAN UNION MEDICAL IMAGING MARKET SIZE, BY NUCLEAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 228. EUROPEAN UNION MEDICAL IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 229. EUROPEAN UNION MEDICAL IMAGING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 230. EUROPEAN UNION MEDICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 231. EUROPEAN UNION MEDICAL IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 232. EUROPEAN UNION MEDICAL IMAGING MARKET SIZE, BY ANATOMY, 2018-2032 (USD MILLION)
  • TABLE 233. EUROPEAN UNION MEDICAL IMAGING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 234. BRICS MEDICAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 235. BRICS MEDICAL IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 236. BRICS MEDICAL IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 237. BRICS MEDICAL IMAGING MARKET SIZE, BY NUCLEAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 238. BRICS MEDICAL IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 239. BRICS MEDICAL IMAGING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 240. BRICS MEDICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 241. BRICS MEDICAL IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 242. BRICS MEDICAL IMAGING MARKET SIZE, BY ANATOMY, 2018-2032 (USD MILLION)
  • TABLE 243. BRICS MEDICAL IMAGING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 244. G7 MEDICAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 245. G7 MEDICAL IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 246. G7 MEDICAL IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 247. G7 MEDICAL IMAGING MARKET SIZE, BY NUCLEAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 248. G7 MEDICAL IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 249. G7 MEDICAL IMAGING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 250. G7 MEDICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 251. G7 MEDICAL IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 252. G7 MEDICAL IMAGING MARKET SIZE, BY ANATOMY, 2018-2032 (USD MILLION)
  • TABLE 253. G7 MEDICAL IMAGING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 254. NATO MEDICAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 255. NATO MEDICAL IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 256. NATO MEDICAL IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 257. NATO MEDICAL IMAGING MARKET SIZE, BY NUCLEAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 258. NATO MEDICAL IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 259. NATO MEDICAL IMAGING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 260. NATO MEDICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 261. NATO MEDICAL IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 262. NATO MEDICAL IMAGING MARKET SIZE, BY ANATOMY, 2018-2032 (USD MILLION)
  • TABLE 263. NATO MEDICAL IMAGING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 264. GLOBAL MEDICAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 265. UNITED STATES MEDICAL IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 266. UNITED STATES MEDICAL IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 267. UNITED STATES MEDICAL IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 268. UNITED STATES MEDICAL IMAGING MARKET SIZE, BY NUCLEAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 269. UNITED STATES MEDICAL IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 270. UNITED STATES MEDICAL IMAGING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 271. UNITED STATES MEDICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 272. UNITED STATES MEDICAL IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 273. UNITED STATES MEDICAL IMAGING MARKET SIZE, BY ANATOMY, 2018-2032 (USD MILLION)
  • TABLE 274. UNITED STATES MEDICAL IMAGING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 275. CHINA MEDICAL IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 276. CHINA MEDICAL IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 277. CHINA MEDICAL IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 278. CHINA MEDICAL IMAGING MARKET SIZE, BY NUCLEAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 279. CHINA MEDICAL IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 280. CHINA MEDICAL IMAGING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 281. CHINA MEDICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 282. CHINA MEDICAL IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 283. CHINA MEDICAL IMAGING MARKET SIZE, BY ANATOMY, 2018-2032 (USD MILLION)
  • TABLE 284. CHINA MEDICAL IMAGING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)